National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

gp100-fowlpox vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the melanoma antigen glycoprotein 100 (gp 100) with potential antineoplastic activity. The expression of gp100 may generate a cellular immune response to melanoma cells; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:gold sodium thiomalate, goldenrod, goserelin, gossypol, gp100 antigen
Next:gp100:209-217(210M) peptide vaccine, gp100:280-288(288V) peptide vaccine, gp96-Ig fusion protein-expressing non-small cell lung cancer cell vaccine, GPI-0100, GPX-100

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov